3.3.4 Polyethylene glycol loxenatide The early GLP-1R agonist has many defects, such as multiple injections and a high incidence of adverse reactions in the digestive tract, which limits its clinical application
Novo Nordisks FlexTouch pen is unique in its use of a torque spring mechanism that provides a low activation force, meaning the force of the injection is driven by the internal spring rather than the users thumb pressure
Among American adults who have taken these medications, 62% said they used them both to treat a chronic condition such as diabetes or heart disease and to lose weight, including 39% who said they used the medications only to treat a chronic condition
Your current health statusincluding liver function, kidney function, and thyroid healthinfluences whether you can safely begin GLP-1 therapy
Novo Nordisk in March won the FDAs approval for Wegovy to lower the risk of cardiovascular death, heart attack and stroke in overweight or obese patients with cardiovascular diseases